$200 Million Revenue and a 15% Growth Rate: How Puris Proteins is Capitalizing on the ‘Ozempic Generation’
A single statistic encapsulates the shift underway in the American food system: pea protein sales are growing at 15% annually – five times faster than established food brands. This isn’t a broad industry trend; it’s the story of Minneapolis-based Puris Proteins, a family-run AgTech company quietly becoming a powerhouse supplier to a nation increasingly focused on protein intake, particularly as demand surges from users of GLP-1 weight loss drugs like Ozempic. Follow the money, and it leads directly to Tyler Lorenzen, CEO of Puris Proteins, and a decades-long bet on the power of plant-based protein.
The company, currently estimated at a value of at least $400 million with Lorenzen and his sister, Nicole Atchison, retaining majority ownership, didn’t emerge overnight. Founded in 1985 by Lorenzen’s parents, it began as a basement operation breeding soybeans. Today, Puris manages a network of hundreds of farmers across 20 states, producing around 3 million bushels annually, and supplies ingredients to 200 major food brands, including giants like Cargill and fast-growing startups like Ritual. This vertically integrated model – controlling both seed development and ingredient processing – is the key to Puris’s current success, and a deliberate strategy built over forty years.
See the original Forbes story for the full account.
The timing couldn’t be more opportune. As approximately 31 million American adults – 12% of the population – now utilize weight-loss drugs, the demand for protein-rich foods is skyrocketing. “What GLP1-users all want is to get more protein in their diet,” Lorenzen explains, highlighting a direct cause-and-effect relationship. The drugs suppress appetite, but users actively seek ways to maximize nutritional intake with smaller portions. Puris is positioned to deliver, offering not just pea protein, but also soy and corn seed varieties bred for high protein content. This focus on maximizing protein density, a core tenet since the company’s inception, is now paying dividends.
A pivotal moment arrived in 2018 with a joint venture with Cargill, resulting in a $100 million investment to convert a former dairy plant in Dawson, Minnesota, into a 200,000-square-foot manufacturing facility. This expansion wasn’t simply about increasing capacity; it was about securing domestic control of the supply chain. Unlike many competitors, Puris has steadfastly avoided genetically modified organisms (GMOs), a decision rooted in the founder, Jerry Lorenzen’s, belief in maintaining genetic independence. This commitment, while initially challenging, has become a competitive advantage, appealing to a growing segment of consumers prioritizing non-GMO ingredients. The company has raised over $250 million in total funding, including a $4 million investment in 2012 from Barbados-based Portland Private Equity and subsequent backing from investors connected to the acquisition of protein powder brand Vega by WhiteWave Foods in 2015.
The Lorenzen family’s long-term vision extends beyond simply capitalizing on the current GLP-1 trend. Nicole Atchison, CEO of Puris Holdings, emphasizes a strategy of “building regional independence, what our dad called ‘protein independence.’” This isn’t about short-term profits; it’s about establishing a resilient, domestically-sourced protein supply chain. Their latest innovation – a 98% soluble clear protein – exemplifies this forward-thinking approach. Unlike traditional protein powders, this new formulation is designed for beverages, opening doors to protein-infused sodas and even cocktails, specifically targeting the “Gen GLP-1” consumer who wants nutritional benefits without the feeling of fullness.
However, Puris’s success isn’t without its context within the broader agricultural landscape. The seed industry has undergone significant consolidation in recent years, with mergers like Dow and DuPont (forming Corteva) and Bayer’s acquisition of Monsanto reshaping the market. Puris’s independent stance, while a strength, also presents challenges in competing with the scale and resources of these industry giants. The company’s ability to maintain its non-GMO status and continue innovating will be crucial in navigating this competitive environment.
What this means for your wallet: Expect to see more protein-enriched products on grocery store shelves, and potentially a slight price increase as demand for pea protein continues to rise. More importantly, watch for the emergence of clear protein beverages – a signal that Puris Proteins is successfully expanding beyond traditional protein powder applications and shaping the future of functional food and drink. The key question now is whether Puris can maintain its growth trajectory as the GLP-1 market matures and larger food companies inevitably attempt to replicate its success.
